Corona Virus Drug Discovery

Coronaviruses (CoVs) are distributed worldwide and have various susceptible hosts; CoVs infecting humans are called human coronaviruses (HCoVs). Although HCoV-specific drugs are still lacking, many potent targets for drug discovery are being explored, and many vigorously designed clinical trials are being carried out in an orderly manner. During the spread of COVID-19 outbreak, great efforts have been made in therapeutic drug discovery against the virus, although the pharmacological effects and adverse reactions of some drugs under study are still unclear. However, well-designed high-quality studies are needed to further study the effectiveness and safety of these potential drugs so as to provide valid recommendations for better control of the COVID-19 pandemic. 

• COVID-19 Vaccines
• Screening Procedures
• Case Reports and Clinical Trials
• Drug Developments & Trials
• Immune Response

Pharmaceutics Conferences  inviting workshop proposals which covers Drug discovery, Vaccines, Guidelines and Protocols for clinical trials, Case reports, Drug quality, safety and efficacy.

Clinical Pharmacy Conferences  welcoming short course proposals on Corona virus epidemiology.

Market Statistics:

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. COVID-19 Diagnostics Market Size 2021 | Is Projected to Reach USD 6.22 Billion by 2027, Exhibiting a CAGR of 2.7%.